APA

Heinzerling L. M., Urbanek M., Funk J. O., Peker S., Bleck O., Neuber K., Burg G., von Den Driesch P. & Dummer R. (20001120). Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. : Cancer.

Chicago

Heinzerling L M, Urbanek M, Funk J O, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P and Dummer R. 20001120. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. : Cancer.

Harvard

Heinzerling L. M., Urbanek M., Funk J. O., Peker S., Bleck O., Neuber K., Burg G., von Den Driesch P. and Dummer R. (20001120). Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. : Cancer.

MLA

Heinzerling L M, Urbanek M, Funk J O, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P and Dummer R. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. : Cancer. 20001120.